QuPath: Open source software for digital pathology image analysis
Peter Bankhead,Maurice B Loughrey,Maurice B Loughrey,José A Fernández,Yvonne Dombrowski,Darragh G. McArt,Philip D Dunne,Stephen McQuaid,Stephen McQuaid,Ronan T. Gray,Liam J. Murray,Helen G. Coleman,Jacqueline A James,Jacqueline A James,Manuel Salto-Tellez,Manuel Salto-Tellez,Peter W. Hamilton +16 more
TL;DR: QuPath provides researchers with powerful batch-processing and scripting functionality, and an extensible platform with which to develop and share new algorithms to analyze complex tissue images, making it suitable for a wide range of additional image analysis applications across biomedical research.
read more
Abstract: QuPath is new bioimage analysis software designed to meet the growing need for a user-friendly, extensible, open-source solution for digital pathology and whole slide image analysis. In addition to offering a comprehensive panel of tumor identification and high-throughput biomarker evaluation tools, QuPath provides researchers with powerful batch-processing and scripting functionality, and an extensible platform with which to develop and share new algorithms to analyze complex tissue images. Furthermore, QuPath’s flexible design makes it suitable for a wide range of additional image analysis applications across biomedical research.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
The human tumor microbiome is composed of tumor type–specific intracellular bacteria
Deborah Nejman,Ilana Livyatan,Garold Fuks,Nancy Gavert,Yaara Zwang,Leore T. Geller,Aviva Rotter-Maskowitz,Roi Weiser,Roi Weiser,Giuseppe Mallel,Elinor Gigi,Arnon Meltser,Gavin M. Douglas,Iris Kamer,Vancheswaran Gopalakrishnan,Tali Dadosh,Smadar Levin-Zaidman,Sofia Avnet,Tehila Atlan,Zachary A. Cooper,Reetakshi Arora,Alexandria P. Cogdill,Abdul Wadud Khan,Gabriel Ologun,Yuval Bussi,Adina Weinberger,Maya Lotan-Pompan,Ofra Golani,Gili Perry,Merav Rokah,Keren Bahar-Shany,Elisa A. Rozeman,Christian U. Blank,Anat Ronai,Ron Shaoul,Amnon Amit,Amnon Amit,Tatiana Dorfman,Ran Kremer,Zvi R. Cohen,Zvi R. Cohen,Sagi Harnof,Sagi Harnof,Tali Siegal,Einav Yehuda-Shnaidman,Einav Nili Gal-Yam,Hagit Shapira,Nicola Baldini,Morgan G. I. Langille,Alon Ben-Nun,Alon Ben-Nun,Bella Kaufman,Bella Kaufman,Aviram Nissan,Talia Golan,Talia Golan,Maya Dadiani,Keren Levanon,Keren Levanon,Jair Bar,Jair Bar,Shlomit Yust-Katz,Shlomit Yust-Katz,Iris Barshack,Iris Barshack,Daniel S. Peeper,Dan J. Raz,Eran Segal,Jennifer A. Wargo,Judith Sandbank,Noam Shental,Ravid Straussman +71 more
TL;DR: A comprehensive analysis of the tumor microbiome was undertaken, studying 1526 tumors and their adjacent normal tissues across seven cancer types, finding that each tumor type has a distinct microbiome composition and that breast cancer has a particularly rich and diverse microbiome.
1.6K
Resolving the fibrotic niche of human liver cirrhosis at single cell level
Prakash Ramachandran,Ross Dobie,John R. Wilson-Kanamori,Elena Dora,Beth E. P. Henderson,N T Luu,N T Luu,Jordan R. Portman,Kylie P. Matchett,M Brice,John A. Marwick,Richard S Taylor,Mirjana Efremova,Roser Vento-Tormo,Neil O. Carragher,Timothy J. Kendall,Jonathan A. Fallowfield,Ewen M Harrison,David R. Mole,David R. Mole,Stephen J. Wigmore,Stephen J. Wigmore,Philip N. Newsome,Philip N. Newsome,Christopher J. Weston,Christopher J. Weston,John P. Iredale,Frank Tacke,Jeffrey W. Pollard,Jeffrey W. Pollard,Chris P. Ponting,John C. Marioni,John C. Marioni,John C. Marioni,Sarah A. Teichmann,Sarah A. Teichmann,Sarah A. Teichmann,Neil C. Henderson +37 more
TL;DR: Analysis of transcriptomes of more than 100,000 single human cells yields molecular definitions for non-parenchymal cell types that are found in healthy and cirrhotic human liver, and identifies markers for scar-associated macrophages and endothelial cells.
Hover-Net: Simultaneous segmentation and classification of nuclei in multi-tissue histology images
Simon Graham,Quoc Dang Vu,Shan E Ahmed Raza,Ayesha Azam,Yee Wah Tsang,Jin Tae Kwak,Nasir M. Rajpoot +6 more
TL;DR: A novel convolutional neural network is presented for simultaneous nuclear segmentation and classification that leverages the instance-rich information encoded within the vertical and horizontal distances of nuclear pixels to their centres of mass to separate clustered nuclei, resulting in an accurate segmentation.
1.1K
CellProfiler 4: improvements in speed, utility and usability.
David R. Stirling,Madison J. Swain-Bowden,Alice Lucas,Anne E. Carpenter,Beth A. Cimini,Allen Goodman +5 more
TL;DR: The CellProfiler 4 as discussed by the authors is a new version of this software with expanded functionality based on user feedback, and it has made several user interface refinements to improve the usability of the software.
Predicting survival from colorectal cancer histology slides using deep learning: A retrospective multicenter study.
Jakob Nikolas Kather,Johannes Krisam,Pornpimol Charoentong,Pornpimol Charoentong,Tom Luedde,Esther Herpel,Cleo Aron Weis,Timo Gaiser,Alexander Marx,Nektarios A. Valous,Nektarios A. Valous,Dyke Ferber,Dyke Ferber,Lina Jansen,Constantino Carlos Reyes-Aldasoro,Inka Zörnig,Inka Zörnig,Dirk Jäger,Dirk Jäger,Hermann Brenner,Jenny Chang-Claude,Michael Hoffmeister,Niels Halama +22 more
TL;DR: It is shown that a CNN can assess the human tumor microenvironment and predict prognosis directly from histopathological images and was an independent prognostic factor for overall survival in a multivariable Cox proportional hazard model.
References
Patterns of p53 immunoreactivity in endometrial carcinomas: ‘all or nothing’ staining is of importance
TL;DR: The authors point out that both diffuse intense nuclear staining and totally absent staining are aberrant patterns of p53 immunoreactivity, and may be found in dysplastic Barrett’s epithelium, and this pattern of staining is referred to as ‘wildtype’ pattern staining.
88
Prognostic role of PD-L1 in malignant solid tumors: a meta-analysis.
TL;DR: The results show that PD-L1 expression rates and the correlations with survival varied between tumor types, and detailed evaluation criteria for PD- L1 will have to be standardized before application to specific tumor types.
55
Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant Chemotherapy.
Philip D Dunne,Darragh G. McArt,Paul G. O’Reilly,Helen G. Coleman,Wendy L. Allen,Maurice B. Loughrey,Sandra Van Schaeybroeck,Simon S. McDade,Manuel Salto-Tellez,Daniel B. Longley,Mark Lawler,Patrick G. Johnston +11 more
TL;DR: Encouraging evidence is provided that patients with PD-L1high/MSI/immunehigh stage II/III colorectal carcinoma should not receive standard chemotherapy and should be evaluated for PD-1 blockade treatment.
45
SlideToolkit: An Assistive Toolset for the Histological Quantification of Whole Slide Images
Bastiaan G. L. Nelissen,Joost A. van Herwaarden,Frans L. Moll,Paul J. van Diest,Gerard Pasterkamp +4 more
TL;DR: The slideToolkit is demonstrated by a repeated measurement of 303 digital slides containing CD3 stained (DAB) abdominal aortic aneurysm tissue from a tissue biobank, which showed an intraclass correlation of 0.99.
P53 abnormalities and outcomes in colorectal cancer: a systematic review
TL;DR: A systematic review of studies that investigated the effect of abnormalities of the tumour suppressor gene p53 upon prognosis in patients with colorectal cancer found evidence of both publication bias and heterogeneity of results.